BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  SoCal’s Peregrine Names a New CEO, to Change Name to Avid Bioservices

  Dr. Lias succeeds Steven W. King, who resigned as president and chief executive officer of Peregrine to pursue other professional interests.

  December 27, 2017

   · 

  5 min read
• 

  FDA

  FDA Green Lights Anika’s Injectable HA-Based Bone Repair Treatment

  The treatment is indicated for filling bone voids or defects of the skeletal system.

  December 27, 2017

   · 

  6 min read
• Momentum Builds for CanniMed’s Acquisition of Newstrike as Regulators Confirm 105 Day Minimum Deposit Period Should Not Be Shortened

  Aurora’s attempt to reduce the minimum bid period was inappropriate and clearly an attempt to pressure CanniMed shareholders into tendering to the coercive Hostile Bid by unfairly shortening the statutorily required bid period.

  December 27, 2017

   · 

  9 min read
• Biotech Beach

  Astute Medical’s Test for AKI Risk Assessment Could Lead to Safer ICU Care

  The study also showed distinct biomarker level increases indicating when major surgery and nonsteroidal anti-inflammatory drugs put patients at risk of AKI.

  December 27, 2017

   · 

  7 min read
• Business

  NeuroRx Signs Agreement With U.S. Dept. of Veterans Affairs and Baylor College of Medicine for Clinical Trial of First Drug Regimen Targeting Severe Bipolar Depression in Patients With Acute Suicidal Ideation & Behavior (ASIB)

  The collaboration also includes Baylor College of Medicine, in Houston, TX.

  December 27, 2017

   · 

  5 min read
• Drug Development

  BiondVax Plans Phase III Clinical Trial Following Receipt of Scientific Advice From the EMA

  BiondVax announced today that the EMA’s CHMP reviewed BiondVax’s Phase 3 trial plan, provided advice, and allowed the Company to proceed with the Phase 3 clinical trial plan for M-001, BiondVax’s universal flu vaccine candidate.

  December 27, 2017

   · 

  4 min read
• Teva Announces Exclusive Launch of a Generic Version of Reyataz in the United States

  Atazanavir sulfate capsules are a protease inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 6 years and older weighing at least 15 kg.

  December 27, 2017

   · 

  9 min read
• Business

  Keryx Biopharma and Siegfried Enter Into a Master Manufacturing Services and Supply Agreement

  The Agreement has an initial term ending on December 31, 2021 and will automatically renew after that for successive terms of one year each.

  December 27, 2017

   · 

  1 min read
• BioMidwest

  Medizone International Attending the J.P. Morgan 36th Annual Healthcare Conference for Partnership and Investment Discussions

  Medizone announced today the Company’s management will be attending the J.P. Morgan 36th Annual Healthcare Conference in San Francisco, January 8th through 11th.

  December 27, 2017

   · 

  2 min read
• ProQR Announces Extraordinary General Meeting of Shareholders

  All relevant documents and information for the meeting, including the notice and agenda, are or will be made available on ProQR’s website.

  December 27, 2017

   · 

  1 min read